Fri, Nov 21, 2014, 2:13 PM EST - U.S. Markets close in 1 hr 47 mins


% | $
Quotes you view appear here for quick access.

Oramed Pharmaceuticals Inc. Message Board

  • glendalelad glendalelad Feb 13, 2014 3:05 PM Flag

    Dangerous short : It's cheaper for Novo Nordisk to buy Oramed at $150/ share

    According to Seeking Alpha article dated Feb 6th , Novo Nordisk are spending $3.65b of their own money on R&D for oral insulin tablet. It would be cheaper for them to buy Oramed for $150/ share ( ten times the current mkt cap) ... and they would get a drug which is more advanced ( a year or two ahead of Novo's trials) ... they would also take out a potential competitor before it possibly teams up with big pharma. They would maintain their quasi-monopoly. Shorts are playing to make $15 downside... but could lose $150 upside. Only a madman would short this... foolish risk-reward.

    Sentiment: Buy

6.5832-0.0868(-1.30%)1:48 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.